Stuart Blincko Email
Chief Technology Officer @ Nanophage Technologies Limited
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Stuart Blincko Location
- Germany
Stuart Blincko Work
- Chief Technology Officer @ (April 2025 - Present)
- Senior Director, Research and Development for Clinical Diagnostics Division @ (December 2021 - February 2025)
- Senior Staff Scientist @ (March 2021 - November 2021)
- working with two Professors on a diagnostics start up pre-launch phase @ . (October 2020 - March 2021)
- Head of R and D at IDS @ (July 2017 - October 2020)
- Senior Director, Transfusion Diagnostics R and D @ (August 2014 - June 2017)
- R and D Director International @ (August 2013 - June 2017)
- Senior Principal Research Scientist @ (November 2011 - July 2013)
- Leading European Discovery Research Teams @ (November 2009 - July 2013)
- Project leader leading Architect assay development @ (January 2005 - November 2009)
- Research Associate @ (May 2002 - January 2005)
- Senior Biochemist and honarary lecturer @ St Bartholomew's Hospital (January 1993 - January 2002)
- Team Leader @ Therapeutic Antibodies Ltd (February 1988 - December 1991)
Stuart Blincko Education
- City St George’s, University of London
PhD (Fluorescence bioconjugation)
1984-1989 - Durham University
BSc Hons (Chemistry)
1981-1984 - Dulwich College
O and A levels (Rugby, Royal Naval CCF, Christian Union)
1974-1981
Stuart Blincko Skills
- R&D
- Life Sciences
- Biochemistry
- Immunoassays
- Diagnostics
- Research
- Design Control
- Infectious Diseases
- ELISA
- Commercialization
- Biotechnology
- Technology Evaluation
- Cross-functional Team Leadership
- FMEA
- Data Analysis
- Science
- Risk Management
- Lifesciences
- Technology Transfer
- Assay Development
- Hardware Diagnostics
- Drug Discovery
- Cancer
- Drug Development
- Immunology
- Protein Chemistry
- Medical Diagnostics
- Microsoft Word
- Cross Functional Team
- PowerPoint
- Cross Functional Team Leadership
- Integration
Stuart Blincko Summary
- Stuart Blincko, based in Germany, is currently a Chief Technology Officer at Nanophage Technologies Limited. Stuart Blincko brings experience from previous roles at Thermo Fisher Scientific, . and Immunodiagnostic Systems (IDS). Stuart Blincko holds a 1984 - 1989 PhD in Fluorescence bioconjugation @ City St George’s, University of London. With a robust skill set that includes R&D, Life Sciences, Biochemistry, Immunoassays, Diagnostics and more. Stuart Blincko has 2 emails on RocketReach.
Looking for a different Stuart Blincko?
Find contact details for 700 million professionals.
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co